These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 22776935

  • 21. Resolution of diabetic papillopathy after a single intravitreal injection of ranibizumab.
    Willerslev A, Munch IC, Larsen M.
    Acta Ophthalmol; 2012 Aug; 90(5):e407-9. PubMed ID: 22268957
    [No Abstract] [Full Text] [Related]

  • 22. Comparison of intravitreal bevacizumab and ranibizumab treatment for diabetic macular edema.
    Ozturk BT, Kerimoglu H, Bozkurt B, Okudan S.
    J Ocul Pharmacol Ther; 2011 Aug; 27(4):373-7. PubMed ID: 21631366
    [Abstract] [Full Text] [Related]

  • 23. Intravitreal anti-VEGF bevacizumab (Avastin) for external beam related radiation retinopathy.
    Finger PT, Mukkamala SK.
    Eur J Ophthalmol; 2011 Aug; 21(4):446-51. PubMed ID: 21218391
    [Abstract] [Full Text] [Related]

  • 24. Short-term safety and efficacy of intravitreal bevacizumab for pseudophakic cystoid macular edema.
    Barone A, Russo V, Prascina F, Delle Noci N.
    Retina; 2009 Jan; 29(1):33-7. PubMed ID: 18854783
    [Abstract] [Full Text] [Related]

  • 25. Intravitreal bevacizumab (Avastin) for the treatment of cystoid macular edema in Behçet disease.
    Mirshahi A, Namavari A, Djalilian A, Moharamzad Y, Chams H.
    Ocul Immunol Inflamm; 2009 Jan; 17(1):59-64. PubMed ID: 19294576
    [Abstract] [Full Text] [Related]

  • 26. Effect of intravitreal triamcinolone in diabetic macular edema unresponsive to intravitreal bevacizumab.
    Jeon S, Lee WK.
    Retina; 2014 Aug; 34(8):1606-11. PubMed ID: 24553409
    [Abstract] [Full Text] [Related]

  • 27. Improvement of diabetic retinopathy with intravitreal Ranibizumab.
    Kernt M, Cserhati S, Seidensticker F, Liegl R, Kampik A, Neubauer A, Ulbig MW, Reznicek L.
    Diabetes Res Clin Pract; 2013 Apr; 100(1):e11-3. PubMed ID: 23391744
    [Abstract] [Full Text] [Related]

  • 28. Treatment of serous macular detachment associated with circumscribed choroidal hemangioma.
    Kwon HJ, Kim M, Lee CS, Lee SC.
    Am J Ophthalmol; 2012 Jul; 154(1):137-145.e1. PubMed ID: 22465363
    [Abstract] [Full Text] [Related]

  • 29. Repeated intravitreal bevacizumab injection with and without macular grid photocoagulation for treatment of diffuse diabetic macular edema.
    Solaiman KA, Diab MM, Dabour SA.
    Retina; 2013 Sep; 33(8):1623-9. PubMed ID: 23538584
    [Abstract] [Full Text] [Related]

  • 30. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to central retinal vein occlusion: results of the pan American collaborative retina study group at 24 months.
    Wu L, Arevalo JF, Berrocal MH, Maia M, Roca JA, Morales-Cantón V, Alezzandrini AA, Díaz-Llopis MJ.
    Retina; 2010 Sep; 30(7):1002-11. PubMed ID: 20616679
    [Abstract] [Full Text] [Related]

  • 31. Intravitreal anti-VEGF therapy for macular radiation retinopathy: a 10-year study.
    Finger PT, Chin KJ, Semenova EA.
    Eur J Ophthalmol; 2016 Sep; 26(1):60-6. PubMed ID: 26391167
    [Abstract] [Full Text] [Related]

  • 32. Cat-scratch-disease-associated macular oedema treated with intravitreal ranibizumab.
    Manousaridis K, Peter S, Mennel S.
    Acta Ophthalmol; 2015 Mar; 93(2):e168-70. PubMed ID: 24943325
    [No Abstract] [Full Text] [Related]

  • 33. [Anti-VEGF: one drug for different conditions?].
    Cohen SY, Massin P, Souied E.
    J Fr Ophtalmol; 2013 Jan; 36(1):2-4. PubMed ID: 23290491
    [No Abstract] [Full Text] [Related]

  • 34. Pseudocystic foveal cavitation in tamoxifen retinopathy.
    Doshi RR, Fortun JA, Kim BT, Dubovy SR, Rosenfeld PJ.
    Am J Ophthalmol; 2014 Jun; 157(6):1291-1298.e3. PubMed ID: 24582991
    [Abstract] [Full Text] [Related]

  • 35. Combined therapy with intravitreal bevacizumab and posterior subtenon triamcinolone acetonide injection in diabetic macular oedema.
    Kim HD, Kang KD, Choi KS, Rhee MR, Lee SJ.
    Acta Ophthalmol; 2014 Nov; 92(7):e589-90. PubMed ID: 24866832
    [No Abstract] [Full Text] [Related]

  • 36. Disrupted foveal photoreceptors after combined cystoid spaces and retinal detachment in branch vein occlusion treated with bevacizumab.
    Murakami T, Tsujikawa A, Miyamoto K, Sakamoto A, Ogino K, Muraoka Y, Kurashige Y, Yoshimura N.
    Retina; 2012 Oct; 32(9):1853-61. PubMed ID: 22481482
    [Abstract] [Full Text] [Related]

  • 37. Intravitreal bevacizumab for refractory pseudophakic cystoid macular edema: the Pan-American Collaborative Retina Study Group results.
    Arevalo JF, Maia M, Garcia-Amaris RA, Roca JA, Sanchez JG, Berrocal MH, Wu L, Pan-American Collaborative Retina Study Group.
    Ophthalmology; 2009 Aug; 116(8):1481-7, 1487.e1. PubMed ID: 19545901
    [Abstract] [Full Text] [Related]

  • 38. Bevacizumab compared with macular laser grid photocoagulation for cystoid macular edema in branch retinal vein occlusion.
    Parveen S, Narayanan R, Sambhav K, Bhatia K.
    Retina; 2010 Sep; 30(8):1324-5; author reply 1325. PubMed ID: 20827152
    [No Abstract] [Full Text] [Related]

  • 39. Intravitreal anti-vascular endothelial growth factor therapy with bevacizumab for tuberous sclerosis with macular oedema.
    Saito W, Kase S, Ohgami K, Mori S, Ohno S.
    Acta Ophthalmol; 2010 May; 88(3):377-80. PubMed ID: 18778334
    [Abstract] [Full Text] [Related]

  • 40. Visual improvement in central retinal vein occlusion (CRVO) following intravitreal injections of bevacizumab (Avastin(®) ).
    Algvere PV, Von Wendt G, Gudmundsson J, Seregard S, Kvanta A.
    Acta Ophthalmol; 2010 Dec; 88(8):836-41. PubMed ID: 19900206
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.